Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Trademark Information
Application ID
Status
Sub Status
Date of Application
23 September 2015
Classes
5
Proprietor
415, Shah Nahar Industrial Estate, Dr. E. Moses Road, Worli, Mumbai 400018
Attorney
Vishesh And Associates[10756]
301/302, A Wing, 3 Rd Floor,
Shaheen Chambers, Dawood Baug,
Opp. Pearl Heritage,
Andheri (West), Mumbai 400 058.
Type
Word
State
Maharashtra
Country
Filing Mode
Branch Office
IP Office
MUMBAI
Used Since
28 April 2009
Valid / Upto
23 September 2025
Description
[Class : 5] Medicinal, Pharmaceutical And Ayurvedic Preparations And Substances, Dietetic Food And Substances Adapted For Medical Use, Dietary Supplements For Humans, Nutritional Supplements
PR Details
Cachet Pharmaceuticals Pvt. Ltd., 415, Shah Nahar Industrial Estate, Dr. E. Moses Road, Worli, Mumbai 400018, A Company Registered Under The Companies Act, 1956., Manufacturers And Trading Merchants, (Body Incorporate)
Sign In to Follow Application
All Documents & Correspondence
All Documents & Correspondence
Uploaded Documents
| 1 | TM-1 | 23 Sep 2015 |
| 2 | Additional Representation Sheet | 23 Sep 2015 |
| 2 | Power of Attorney | 23 Sep 2015 |
| 3 | Additional Representation Sheet | 23 Sep 2015 |
| 3 | Power of Attorney | 23 Sep 2015 |
| 4 | Reply to Exam Report (MIS-R) | 15 Mar 2016 |
| 5 | Journal Copy | 11 Oct 2018 |
| 6 | TM-O(NOTICE OF OPPOSITION) | 30 Nov 2018 |
| 7 | Letters related to TOP | 13 May 2019 |
| 8 | Annexure -1 under rule 46 | 10 Jul 2019 |
| 9 | Evidence Affidavit Under Rule 46 (TOP) | 10 Jul 2019 |
| 10 | Evidence Affidavit Under Rule 46 (TOP) | 11 Jul 2019 |
| 11 | Letters related to TOP | 29 Jul 2019 |
| 12 | Order | 14 Oct 2022 |
| 13 | Certificate | 14 Oct 2022 |
Correspondence and Notices
| 1 | Hearing Notice (Show Cause) | 6616450 | 3078913 | 05 Jul 2018 |
| 2 | Tribunal Accepted Notice for : 3061816 | 6809203 | 3101554 | 09 Aug 2018 |
| 3 | Opposition Notice | 7489292 | 3594599 | 19 Dec 2018 |
| 4 | Opposition Counter Statement | 8000305 | 3910103 | 23 Mar 2019 |